2022-11-08T14:35:29-06:00 2021-12-31 521446779 JOHNSON LAMBERT LLP 4242 SIX FORKS ROAD SUITE 1500 RALEIGH NC 27609 990 2021-01-01 320020119 ASTS FOUNDATION ASTS 7034147870 1401 SOUTH CLARK STREET 1120 ARLINGTON VA 22202 MAGGIE KEBLER-BULLOCK EXECUTIVE DIRECTOR 7034147870 2022-11-08 1 MAGGIE KEBLER-BULLOCK 999009999 J CALVIN MARKS P01226973 9197196400 0 AAL1 IAL1 2021 2022-09-23 18:48:47Z MAGGIE KEBLER-BULLOCK 1401 SOUTH CLARK STREET 1120 ARLINGTON VA 22202 6985248 0 X WWW.ASTS.ORG/ASTS-FOUNDATION X 2002 VA PROMOTE PHILANTHROPY IN THE FIELD OF TRANSPLANT SURGERY. 12 12 0 50 0 0 958166 579702 0 0 -11490 1365671 0 0 946676 1945373 946676 899500 966627 0 62353 54562 0 0 31295 165242 155140 2140898 1109202 -1194222 836171 22344684 24421604 513421 540869 21831263 23880735 THE MISSION OF THE ASTS FOUNDATION IS TO PROMOTE PHILANTHROPY IN THE FIELD OF TRANSPLANT SURGERY. FUNDS GENERATED WILL BE USED TO PROVIDE SUPPORT FOR ASTS SPONSORED INITIATIVES SUCH AS EDUCATION, FELLOWSHIPS AND OTHER TRAINING, AND RESEARCH. 0 0 938510 899500 THE FOUNDATION, THROUGH STRATEGIC PARTNERSHIPS, PROVIDES FUNDING FOR RESEARCH GRANTS DESIGNED TO ADVANCE THE FIELD OF ORGAN TRANSPLANTATION. RESEARCH GRANTS ARE AVAILABLE TO THE SOCIETY'S MEMBERS AND THEIR TRAINEES THROUGHOUT THE UNITED STATES AND CANADA. SINCE THE PROGRM'S INCEPTION, OVER 300 PEOPLE HAVE RECEIVED MORE THAN $13M IN RESEARCH GRANT FUNDING. IN 2021, THE ASTS FOUNDATION AWARDED $899K IN GRANT FUNDING TO 32 RECIPIENTS. 938510 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 X 2 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 12 12 0 0 0 0 0 1 0 1 1 0 0 1 1 1 1 1 1 0 0 0 AL AK AZ CA CO DE FL GA IL KS KY ME CT OR VA OK PA RI TN UT TX WA WV WI MA MD MN MI MO NJ NM NY NC ND OH SC X MAGGIE KEBLER-BULLOCK 7034147870 1401 SOUTH CLARK STREET 1120 ARLINGTON VA 22202 MAGGIE KEBLER-BULLOCK CFRE EXECUTIVE DIRECTOR 2.00 38.00 X 0 185000 39320 DIANE MOSSHOLDER MA CAE CHIEF OPERATING OFFICER 2.00 38.00 X 0 120000 18623 JOHN P ROBERTS MD CHAIR 0.50 X X 0 0 0 THOMAS G PETERS MD FACS VICE CHAIR 0.50 X X 0 0 0 JAMES MARKMANN MD PHD TREASURER (FROM MAY '21) 0.50 0.50 X X 0 0 0 GINNY L BUMGARDNER MD PHD SECRETARY 0.50 0.50 X X 0 0 0 MARWAN ABOULJOUDMD FACS MMM CPE DIRECTOR (TO MAY '21) 0.50 5.00 X 0 0 0 WILLIAM C CHAPMAN MD DIRECTOR 0.50 1.00 X 0 0 0 KENNETH CHAVIN MD PHD DIRECTOR 0.50 X 0 0 0 MATTHEW COOPER MD DIRECTOR 0.50 0.50 X 0 0 0 OSAMA GABER MD FACS DIRECTOR 0.50 5.00 X 0 0 0 JULIE K HEIMBACH MD DIRECTOR (TO MAY '21) 0.50 0.50 X 0 0 0 IRENE K KIM MD DIRECTOR 0.50 0.50 X 0 0 0 GORAN B KLINTMALM MD PHD DIRECTOR (TO MAY '21) 0.50 X 0 0 0 JAYME LOCK MD MPH DIRECTOR (FROM MAY '21) 0.50 0.50 X 0 0 0 CHRISTOPHER L MARSH MD FACS DIRECTOR 0.50 X 0 0 0 GEORGINE SMITH MS PA-C MHS DIRECTOR (FROM MAY '21) 0.50 X 0 0 0 0 305000 57943 0 0 1 0 JP MORGAN CHASE BANK NA 270 PARK AVE NEW YORK NY 10017 INVESTMENT MANAGEMENT SERVICES 101160 1 579702 579702 652011 652011 5753535 5039875 713660 713660 713660 1945373 0 0 1365671 899500 899500 43201 29696 12879 626 11361 -12433 5558 18236 339 339 5315 76 5239 101160 101160 2721 2694 12 15 4077 732 3164 181 7162 2735 4426 1 4371 4371 100 35 51 14 597 391 194 12 822 822 955 122 833 TAXES 11955 72 11883 HONORARIA 9673 9673 DUES AND SUBSCRIPTIONS 2574 1984 263 327 3319 3305 14 1109202 938510 139397 31295 1259925 1113286 392450 109950 46951 20692309 23151417 22344684 24421604 3500 248369 392500 292500 117421 0 513421 540869 X 20564983 22706820 1266280 1173915 21831263 23880735 22344684 24421604 X 836171 1109039 104262 X 0 1 X 1 1 1 X X 1 ASTS 133048373 7 1 0 938510 1 0 938510 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X PART X, LINE 2: MANAGEMENT EVALUATED THE FOUNDATION'S TAX POSITIONS AND CONCLUDED THAT THE FOUNDATION HAS TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE CONSOLIDATED FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF THIS GUIDANCE. GENERALLY, THE FOUNDATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY THE U.S. FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS BEFORE 2017. 1 FACULTY DEVELOPMENT GRANT 4 200000 RESEARCH GRANT 8 167500 RESIDENT SCIENTIST SCHOLARSHIP 4 160000 COLLABORATIVE SCIENTIST GRANT 2 100000 FELLOWSHIP TRANSPLANTATION GRANT 2 85000 CSL BEHRING MID-LEVEL GRANT 1 50000 ENHANCING ORGAN DONATION & TRANSPLANTATION GRANT 1 50000 SOCIO ECONOMIC & RACIAL DISPARITY GRANT 2 50000 PRESIDENTIAL STUDENT MENTORSHIP GRANT 8 37000 PART I, LINE 2: GRANTS ARE AWARDED BASED ON A COMPETITIVE REVIEW BY THE FOUNDATION'S LEADERSHIP, GRANTS REVIEW COMMITTEE MEMBERS AND MEMBERS-AT-LARGE. A BUDGET IS REQUIRED FOR EACH GRANT APPLICATION AND ANY VARIANCE FROM THE SUBMITTED BUDGET REQUIRES APPROVAL OF THE GRANTS REVIEW COMMITTEE. FOR GRANTS $10,000 AND GREATER, CHECKS ARE ISSUED TO THE INSTITUTION, OFTEN IN TWO INSTALLMENTS. PRIOR TO DISPERSING THE SECOND INSTALLMENT, A PROGRESS REPORT IS DUE TO THE FDN. ANY CONCERNS ARE ADDRESSED PRIOR TO ISSUING THE REMAINING FUNDS. GRANTS OF LESS THAN $10,000 ARE PAID AS A SINGLE PAYMENT. 0 0 0 0 0 0 0 0 0 MAGGIE KEBLER-BULLOCK CFRE EXECUTIVE DIRECTOR 0 185000 0 0 0 0 0 9250 0 30070 0 224320 0 0 SCHEDULE J, PART I, LINE 3: THE FOUNDATION DOES NOT DIRECTLY HIRE OR COMPENSATE EMPLOYEES. ALL EMPLOYEES ARE EMPLOYEES OF THE SOCIETY, A RELATED ORGANIZATION. THE COST OF THE SOCIETY'S OFFICER AND HIGHLY COMPENSATED EMPLOYEES ARE ALLOCATED UNDER THE TERMS OF A COST SHARING AGREEMENT. EXECUTIVE COMMITTEE CONDUCTS AN ANNUAL REVIEW WITH INPUT FROM COMMITTEE CHAIRS AND COUNCIL MEMBERS. THE SOCIETY'S COMPENSATION COMMITTEE ANALYZES RELEVANT BENCHMARK DATA, REVIEWS THE EVALUATIONS AND MAKES RECOMMENDATIONS TO THE SOCIETY'S COUNCIL/BOARD FOR LEVEL OF COMPENSATION. FORM 990, PART V, LINE 2A: THE FOUNDATION DOES NOT DIRECTLY HIRE OR COMPENSATE EMPLOYEES. ALL EMPLOYEES ARE EMPLOYEES OF THE SOCIETY, A RELATED ORGANIZATION. THE COST OF THE SOCIETY'S OFFICER AND HIGHLY COMPENSATED EMPLOYEES ARE ALLOCATED UNDER THE TERMS OF A COST SHARING AGREEMENT. AS SUCH, THE FOUNDATION IS REPORTING ZERO EMPLOYEES ON THE FORM W-3 FOR 2021. FORM 990, PART VI, SECTION A, LINE 7A THE AFFILIATED ORGANIZATION, THE SOCIETY, HAS MEMBERS THAT ELECT THE GOVERNING BODY WHICH SERVES BOTH THE SOCIETY AND THE FOUNDATION. FORM 990, PART VI, SECTION B, LINE 11B THE FEDERAL FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTANT AND UPON SUBMISSION OF THE DRAFT, IS REVIEWED BY THE SECRETARY/TREASURER AND EXECUTIVE DIRECTOR. THE FORM 990 IS PRESENTED TO THE BOARD OF DIRECTORS FOR REVIEW AND DISCUSSION PRIOR TO FINALIZING WITH THE INTERNAL REVENUE SERVICE. FORMAL APPROVAL IS RECORDED IN THE MINUTES. FORM 990, PART VI, SECTION B, LINE 12C TO ENSURE ACCURATE, UP TO DATE INFORMATION, EACH BOARD MEMBER REVIEWS HIS OR HER DISCLOSURE STATEMENT DURING FACE-TO-FACE MEETINGS AND UPDATES AS NECESSARY BETWEEN MEETINGS. EACH BOARD MEMBER CLEARLY DESCRIBES HIS OR HER INTEREST IN EACH SUCH ISSUE, SUBJECT, PERSON OR ENTITY ON THIS FORM AND RETURN TO THE FOUNDATION'S EXECUTIVE DIRECTOR. THE INFORMATION ON THIS FORM IS REVIEWED BY THE PRESIDENT AND EXECUTIVE DIRECTOR, AND SHARED WITH THE BOARD OF DIRECTORS IF RELEVANT TO THE DISCUSSION AT HAND. THE BOARD MEMBER MAY VOLUNTARILY RECUSE HIM/HERSELF FROM DISCUSSION AND/OR VOTING ON THE BASIS OF A CONFLICT OF INTEREST. IN ADDITION, THE BOARD OF DIRECTORS MAY REQUIRE THAT THE FOUDATION'S MEMBER: (A) REFRAIN FROM VOTING ON THE ISSUE, (B) NOT PARTICIPATE IN EITHER THE DISCUSSION OR THE VOTE ON THE ISSUE, (C) LEAVE THE ROOM DURING DISCUSSION AND VOTING ON THE ISSUE, OR (D) EXPLAIN HIS OR HER INTEREST IN THE MATTER FULLY SO THE BOARD OF DIRECTORS MAY WEIGH THE BOARD MEMBERS FURTHER PARTICIPATION. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE ON THE PUBLIC PORTION OF THE WEBSITE. FINANCIAL STATEMENTS ARE PROVIDED UPON REQUEST. FORM 990, PART XI, LINE 9: RETURN GRANTS 104,262. AMERICAN SOCIETY OF TRANSPLANT SURGEONS 1401 SOUTH CLARK STREET SUITE 1120 ARLINGTON VA 22202 133048373 PROMOTE EDUCATION, TRAINING & RESEARCH IN ORGAN& CELLULAR OR 501(C)(3) LINE 7 N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0